Skip to main content Back to Top
Advertisement

6/14/2016

Carvedilol Tablets

Products Affected - Description

    • Carvedilol oral tablet, Mylan, 12.5 mg, 500 count, NDC 00378-3633-07
    • Carvedilol oral tablet, Sun Pharma, 12.5 mg, 100 count, NDC 57664-0245-88
    • Carvedilol oral tablet, Sun Pharma, 12.5 mg, 500 count, NDC 57664-0245-13
    • Carvedilol oral tablet, Sun Pharma, 12.5 mg, 1000 count, NDC 57664-0245-18
    • Carvedilol oral tablet, Sun Pharma, 25 mg, 100 count, NDC 57664-0247-88
    • Carvedilol oral tablet, Sun Pharma, 25 mg, 500 count, NDC 57664-0247-13
    • Carvedilol oral tablet, Sun Pharma, 25 mg, 1000 count, NDC 57664-0247-18
    • Carvedilol oral tablet, Sun Pharma, 3.125 mg, 100 count, NDC 57664-0242-88
    • Carvedilol oral tablet, Sun Pharma, 3.125 mg, 500 count, NDC 57664-0242-13
    • Carvedilol oral tablet, Sun Pharma, 3.125 mg, 1000 count, NDC 57664-0242-18
    • Carvedilol oral tablet, Sun Pharma, 6.25 mg, 100 count, NDC 57664-0244-88
    • Carvedilol oral tablet, Sun Pharma, 6.25 mg, 500 count, NDC 57664-0244-13
    • Carvedilol oral tablet, Sun Pharma, 6.25 mg, 1000 count, NDC 57664-0244-18

Reason for the Shortage

    • Glenmark cannot provide a reason for the shortage.
    • Mylan cannot provide a reason for the shortage.
    • Sun Pharma cannot provide availability information at this time.
    • Teva cannot provide a reason for the shortage.

Available Products

    • Coreg oral tablet, GlaxoSmithKline, 12.5 mg, 100 count, NDC 00007-4141-20
    • Coreg oral tablet, GlaxoSmithKline, 25 mg, 100 count, NDC 00007-4142-20
    • Coreg oral tablet, GlaxoSmithKline, 3.125 mg, 100 count, NDC 00007-4139-20
    • Coreg oral tablet, GlaxoSmithKline, 6.25 mg, 100 count, NDC 00007-4140-20
    • Carvedilol oral tablet, Aurobindo, 12.5 mg, 100 count, NDC 65862-0144-01
    • Carvedilol oral tablet, Aurobindo, 12.5 mg, 500 count, NDC 65862-0144-05
    • Carvedilol oral tablet, Aurobindo, 25 mg, 100 count, NDC 65862-0145-01
    • Carvedilol oral tablet, Aurobindo, 25 mg, 500 count, NDC 65862-0145-05
    • Carvedilol oral tablet, Aurobindo, 3.125 mg, 100 count, NDC 65862-0142-01
    • Carvedilol oral tablet, Aurobindo, 3.125 mg, 500 count, NDC 65862-0142-05
    • Carvedilol oral tablet, Aurobindo, 6.25 mg, 100 count, NDC 65862-0143-01
    • Carvedilol oral tablet, Aurobindo, 6.25 mg, 500 count, NDC 65862-0143-05
    • Carvedilol oral tablet, Glenmark, 12.5 mg, 100 count, NDC 68462-0164-01
    • Carvedilol oral tablet, Glenmark, 12.5 mg, 500 count, NDC 68462-0164-05
    • Carvedilol oral tablet, Glenmark, 25 mg, 100 count, NDC 68462-0165-01
    • Carvedilol oral tablet, Glenmark, 25 mg, 500 count, NDC 68462-0165-05
    • Carvedilol oral tablet, Glenmark, 3.125 mg, 100 count, NDC 68462-0162-01
    • Carvedilol oral tablet, Glenmark, 3.125 mg, 500 count, NDC 68462-0162-05
    • Carvedilol oral tablet, Glenmark, 6.25 mg, 100 count, NDC 68462-0163-01
    • Carvedilol oral tablet, Glenmark, 6.25 mg, 500 count, NDC 68462-0163-05
    • Carvedilol oral tablet, Major, 12.5 mg, unit-dose 100 count, NDC 00904-6302-61
    • Carvedilol oral tablet, Major, 25 mg, unit-dose 100 count, NDC 00904-6303-61
    • Carvedilol oral tablet, Major, 3.125 mg, unit-dose 100 count, NDC 00904-6300-61
    • Carvedilol oral tablet, Major, 6.25 mg, unit-dose 100 count, NDC 00904-6301-61
    • Carvedilol oral tablet, Mylan, 12.5 mg, 100 count, NDC 00378-3633-01
    • Carvedilol oral tablet, Mylan, 12.5 mg, 500 count, NDC 00378-3633-05
    • Carvedilol oral tablet, Mylan, 25 mg, 100 count, NDC 00378-3634-01
    • Carvedilol oral tablet, Mylan, 25 mg, 500 count, NDC 00378-3634-05
    • Carvedilol oral tablet, Mylan, 3.125 mg, 100 count, NDC 00378-3631-01
    • Carvedilol oral tablet, Mylan, 3.125 mg, 500 count, NDC 00378-3631-05
    • Carvedilol oral tablet, Mylan, 6.25 mg, 100 count, NDC 00378-3632-01
    • Carvedilol oral tablet, Mylan, 6.25 mg, 500 count, NDC 00378-3632-05
    • Carvedilol oral tablet, Mylan Institutional, 12.5 mg, unit-dose 25 count, NDC 51079-0931-19
    • Carvedilol oral tablet, Mylan Institutional, 12.5 mg, unit-dose 100 count, NDC 51079-0931-20
    • Carvedilol oral tablet, Mylan Institutional, 25 mg, unit-dose 100 count, NDC 51079-0932-20
    • Carvedilol oral tablet, Mylan Institutional, 3.125 mg, unit-dose 25 count, NDC 51079-0771-19
    • Carvedilol oral tablet, Mylan Institutional, 3.125 mg, unit-dose 100 count, NDC 51079-0771-20
    • Carvedilol oral tablet, Mylan Institutional, 6.25 mg, unit-dose 25 count, NDC 51079-0930-19
    • Carvedilol oral tablet, Mylan Institutional, 6.25 mg, unit-dose 100 count, NDC 51079-0930-20
    • Carvedilol oral tablet, Sandoz, 12.5 mg, 100 count, NDC 00781-5223-01
    • Carvedilol oral tablet, Sandoz, 25 mg, 100 count, NDC 00781-5224-01
    • Carvedilol oral tablet, Sandoz, 3.125 mg, 100 count, NDC 00781-5221-01
    • Carvedilol oral tablet, Sandoz, 6.25 mg, 100 count, NDC 00781-5222-01
    • Carvedilol oral tablet, Solco Healthcare US, 12.5 mg, 100 count, NDC 43547-0256-10
    • Carvedilol oral tablet, Solco Healthcare US, 12.5 mg, 500 count, NDC 43547-0256-50
    • Carvedilol oral tablet, Solco Healthcare US, 25 mg, 100 count, NDC 43547-0257-10
    • Carvedilol oral tablet, Solco Healthcare US, 25 mg, 500 count, NDC 43547-0257-50
    • Carvedilol oral tablet, Solco Healthcare US, 3.125 mg, 100 count, NDC 43547-0254-10
    • Carvedilol oral tablet, Solco Healthcare US, 3.125 mg, 500 count, NDC 43547-0254-50
    • Carvedilol oral tablet, Solco Healthcare US, 6.25 mg, 100 count, NDC 43547-0255-10
    • Carvedilol oral tablet, Solco Healthcare US, 6.25 mg, 500 count, NDC 43547-0255-50
    • Carvedilol oral tablet, Teva, 12.5 mg, 100 count, NDC 00093-7295-01
    • Carvedilol oral tablet, Teva, 12.5 mg, 500 count, NDC 00093-7295-05
    • Carvedilol oral tablet, Teva, 25 mg, 100 count, NDC 00093-7296-01
    • Carvedilol oral tablet, Teva, 25 mg, 500 count, NDC 00093-7296-05
    • Carvedilol oral tablet, Teva, 3.125 mg, 100 count, NDC 00093-0051-01
    • Carvedilol oral tablet, Teva, 3.125 mg, 500 count, NDC 00093-0051-05
    • Carvedilol oral tablet, Teva, 6.25 mg, 100 count, NDC 00093-0135-01
    • Carvedilol oral tablet, Teva, 6.25 mg, 500 count, NDC 00093-0135-05
    • Carvedilol oral tablet, Zydus, 12.5 mg, 100 count, NDC 68382-0094-01
    • Carvedilol oral tablet, Zydus, 12.5 mg, 500 count, NDC 68382-0094-05
    • Carvedilol oral tablet, Zydus, 25 mg, 100 count, NDC 68382-0095-01
    • Carvedilol oral tablet, Zydus, 25 mg, 500 count, NDC 68382-0095-05
    • Carvedilol oral tablet, Zydus, 3.125 mg, 100 count, NDC 68382-0092-01
    • Carvedilol oral tablet, Zydus, 3.125 mg, 500 count, NDC 68382-0092-05
    • Carvedilol oral tablet, Zydus, 6.25 mg, 100 count, NDC 68382-0093-01
    • Carvedilol oral tablet, Zydus, 6.25 mg, 500 count, NDC 68382-0093-05

Estimated Resupply Dates

    • Mylan has carvedilol 12.5 mg tablets in 500 count (NDC 00378-3633-07) on back order and the company cannot estimate a release date.
    • Sun Pharma cannot provide availability information at this time.
    • All other marketed presentations are available.

Updated

Updated June 14, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 17, 2015 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.
ADVERTISEMENT